Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 49.31%
March 31, 2026 45.20%
December 31, 2025 44.89%
September 30, 2025 44.40%
June 30, 2025 46.36%
March 31, 2025 45.13%
December 31, 2017 48.31%
September 30, 2017 46.19%
June 30, 2017 44.83%
March 31, 2017 44.04%
December 31, 2016 46.78%
September 30, 2016 46.98%
June 30, 2016 43.30%
March 31, 2016 41.07%
December 31, 2015 39.79%
September 30, 2015 41.50%
June 30, 2015 41.76%
March 31, 2015 39.63%
December 31, 2014 38.69%
September 30, 2014 32.90%
June 30, 2014 41.19%
March 31, 2014 40.20%
December 31, 2013 42.40%
September 30, 2013 41.95%
June 30, 2013 41.51%
Date Value
March 31, 2013 39.96%
December 31, 2012 37.66%
September 30, 2012 38.31%
June 30, 2012 38.20%
March 31, 2012 37.70%
December 31, 2011 35.92%
September 30, 2011 38.30%
June 30, 2011 39.19%
March 31, 2011 40.42%
December 31, 2010 41.00%
September 30, 2010 40.71%
June 30, 2010 40.37%
March 31, 2010 41.17%
December 31, 2009 36.78%
September 30, 2009 35.15%
June 30, 2009 34.23%
March 31, 2009 32.35%
December 31, 2008 40.23%
September 30, 2008 30.19%
June 30, 2008 33.48%
March 31, 2008 32.96%
December 31, 2007 34.91%
September 30, 2007 33.37%
June 30, 2007 34.43%
March 31, 2007 33.58%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Accuray, Inc. 34.76%
Micron Solutions, Inc. --
IDEXX Laboratories, Inc. 64.07%
Medtronic Plc 60.80%
Neogen Corp. 37.59%